Kumar, S., Vij, R., Kaufman, J. L., Mikhael, J., Facon, T., Pegourie, B., … Touzeau, C. (2016). Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 34). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. https://doi.org/10.1200/JCO.2016.34.15_supp1.8032

Kumar, Shaji, Ravi Vij, Jonathan L. Kaufman, Joseph Mikhael, Thierry Facon, Brigitte Pegourie, Lotfi Benboubker, et al. “Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 34. AMER SOC CLINICAL ONCOLOGY, 2016. https://doi.org/10.1200/JCO.2016.34.15_supp1.8032.

Kumar S, Vij R, Kaufman JL, Mikhael J, Facon T, Pegourie B, et al. Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2016.

Kumar, Shaji, et al. “Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 34, no. 15, AMER SOC CLINICAL ONCOLOGY, 2016. Wos, doi:10.1200/JCO.2016.34.15_supp1.8032.

Kumar S, Vij R, Kaufman JL, Mikhael J, Facon T, Pegourie B, Benboubker L, Gasparetto C, Amiot M, Moreau P, Diehl S, Alzate S, Ross JA, Dunbar M, Zhu M, Agarwal SK, Leverson J, Maciag PC, Verdugo ME, Touzeau C. Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2016.